Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Treatment Patterns and Effects for Metastatic Non-small Cell Lung Cancer Patients In NORway (DELINOR)

NCT05834348 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05834348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05834348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Treatment Patterns and Effects for Metastatic Non-small Cell Lung Cancer Patients In NORway (DELINOR)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
June 23, 2023
Completion date
January 23, 2024
Enrollment
5,279 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer